ACAD9 and breast cancer: For the first time, in this study, we identified an ACAD9 variant (Ala326Thr) that was detected in every affected individual with PDAC or its precursor lesions in 4 of 46 (8.7%) FPC families that were characterized by the absence of breast cancer in the pedigree.